THE ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) https://ahrp.org 142 West End Ave. Suite 28P New York, NY 10023 Testimony by The Alliance for Human Research Protection Committee on Ways and Means Hearing on Protections for Foster Children Enrolled in Clinical Trials May 18, 2005 On March 10, 2004, The ALLIANCE…
Major Health Groups Cite Antipsychotic Dangers Psychotropic drugs may be bad for your heart/ Clozaril and Zyprexa Wed, 23 Mar 2005 Obesity and diabetes are the fastest growing health hazard due to bad nutrition and a sedentary life style. However, diabetes is also caused by a class of widely prescribed…
Bioethics Debate: Ethics of U Penn Surgical “Drug Implant” Experiment This debate between AHRP President, Vera Sharav and Bioethicist, Paul Root Volpe, Ph.D., University of Pennsylvania, was prompted by an October 7 infomail. The reasons for AHRP’s opposition to drug implants for psychiatric patients are explained here: https://ahrp.org/ahrpspeaks/drugimplant1103.php —–Original Message—–…
Risperdal Linked to Stroke; Zyprexa linked to Diabetes Fri, 11 Apr 2003 Two highly promoted, best selling neuroleptic drugs (also called, antipsychotics) are linked to life-threatening drug-induced conditions. The Boston Globe reports (below) that elderly people who are prescribed Risperdal are at increased risk of stroke. The manufacturer, Johnson and…
Credibility Crisis:Survey FDA Scientists – Death in NIH-AIDS Trial – Tauzin Moves to PhRMA Thu, 16 Dec 2004 A credibility crisis in medical research is smoldering: like the Enron accounting scandal, the prescription-drug debacle is a matter of systemic corruption, including gross and widespread failure by the regulatory process. Unlike…
TeenScreen: Who Pays for Treatment and Drugs?? Sun, 29 May 2005 In her latest examination of the President’s Commission on Mental Health recommendation for universal mental health screening, Evelyn Pringle focuses on the $$$ it costs and on how screening, followed by prescribing psychotropic drugs, is bankrupting of public health…
ALLIANCE FOR HUMAN RESEARCH PROTECTION* (AHRP) April 10, 2000 Gary Ellis, Ph.D, Director Michael A. Carome, M.D. Chief Compliance Oversight Branch Division of Human Subject Protections Office of Protection from Research Risks Rockville, MD 20892-7507 Re: High Risk Experiment With Children Who Have No Medical Diagnosis Dear Dr. Ellis &…
Antipsychotic Drug Use Doubled since 1996 in Tennessee Children – Why? Thu, 2 Sep 2004 A Vanderbilt University study found that the use of antipsychotic drugs has doubled among poor children in Tennessee. “The increase, seen largely among children diagnosed with attention-deficit/hyperactivity disorder (ADHD), conduct disorder and affective disorders such…
Treating children as young as 4 for bipolar – WSJ Thu, 26 May 2005 A report in The Wall Street Journal should raise serious concerns about the legitimacy of psychiatric diagnosing and drug prescribing for children. The Journal reports that close to 20,000 US children are being diagnosed with bi-polar…
Risks: Drugs / Vaccines / Trials / Treatment Evidence of antidepressant harm Oct 14, 2005: Andrew Finkelstein Letter to Dr. Russell Katz, Director, Neuropharmacological Drug Products, FDA about FDA’s Failure to Warn about Neurontin-Suicides Aug 29: FDA Response to Utah Court Must Be Truthful Re: Zoloft / SSRI Suicidal Risks…
Bush Plans to Screen Whole US Population for Mental Illness – BMJ Thu, 24 Jun 2004 A second article in the British Medical Journal discloses additional evidence uncovered by Allen Jones, the whistle blower from the Pennsylvania Inspector General’s Office. The first BMJ article focused on the Texas Medication Algorithm…
Depressed? NYC Screens for People at Risk – NY Times Wed, 13 Apr 2005 A front page article in The New York Times reports that the New York City Department of Health and Mental Hygiene, has instructed doctors at City hospitals – who care for one in four New Yorkers…
